+Search query
-Structure paper
Title | BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 65, Page 16420-16431, Year 2022 |
Publish date | Nov 18, 2022 (structure data deposition date) |
Authors | Meibom, D. / Micus, S. / Andreevski, A.L. / Anlauf, S. / Bogner, P. / von Buehler, C.J. / Dieskau, A.P. / Dreher, J. / Eitner, F. / Fliegner, D. ...Meibom, D. / Micus, S. / Andreevski, A.L. / Anlauf, S. / Bogner, P. / von Buehler, C.J. / Dieskau, A.P. / Dreher, J. / Eitner, F. / Fliegner, D. / Follmann, M. / Gericke, K.M. / Maassen, S. / Meyer, J. / Schlemmer, K.H. / Steuber, H. / Tersteegen, A. / Wunder, F. |
External links | J. Med. Chem. / PubMed:36475653 |
Methods | X-ray diffraction |
Resolution | 3.3 Å |
Structure data | PDB-8bpy: |
Chemicals | ChemComp-ZN: ChemComp-MG: ChemComp-NA: ChemComp-R4I: |
Source |
|
Keywords | HYDROLASE / PDE9A / inhibitor |